eli lilly glp-1 medications portfolio LLY Stock Widens Lead With Foundayo FDA Approval Why a Pair of Eli

The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials

Johns Wort causes weight gain

Glutathione-Independent Ferroptosis Although described since the beginning to be the main actor of ferroptosis inhibition, it has been recently described that the cysteine-GSH-GPx4 axis can be, at least in part, dispensable

What I want patients and clinicians to take away from this is that if you or your patient has obesity, established cardiovascular disease, type 2 diabetes, CKD, HFpEF, MASH, or sleep apnea, this drug class should be a serious part of the treatment conversation

Lower daily food intake and reduced cravings in the extract group persisted through the full 24 weeks